Exploring the viability of Zeatin as a prospective therapeutic candidate for investigating the complex interplay between severe acute respiratory syndrome coronavirus (SARS-CoV) and Alzheimer’s disease

被引:0
|
作者
A. S. Sriranjini
Ashish Thapliyal
Kumud Pant
机构
[1] Graphic Era Deemed to be University,Department of Biotechnology
关键词
SARS-CoV; COVID; Alzheimer’s; Pharmacology; APOE4; ACE2; SPIKE;
D O I
10.1007/s40203-024-00195-3
中图分类号
学科分类号
摘要
The present research aims to explore the intricate link between SARS-CoV infection and susceptibility to Alzheimer’s disease, focusing on the role of APOE4, a genetic factor associated with both conditions. Our research aims to uncover shared molecular pathways, considering APOE4’s impact on lipid metabolism, immune responses, and neuroinflammation relevant to COVID-19 and AD. The Chyawanprash phytocompounds were subjected to in-silico ADMET profiling and Zeatin a neuroprotective cytokinin emerged as a promising regulator of the ACE2-SPIKE complex as it exhibits favourable pharmacological attributes, presenting as a non-substrate for Permeability glycoprotein, low Protein Binding Percentage, and distinctive toxicity endpoints. Therapeutic candidate. Zeatin’s robust binding disrupts the intricate APOE4-ACE2-SPIKE interplay (AAS), offering a potential therapeutic avenue that is further corroborated by Molecular dynamic simulation as the system remained stable without any major fluctuation throughout the 100ns simulation. The AAS binding free energy, determined as -124.849 +/- 15.513 KJ/mol using MMPBSA assay, reveals significant contributions to complex stability from amino acids including, GLN41: 1.211 kcal/mol, GLU340: 1.188 kcal/mol, ALA344: 1.198 kcal/mol, while ARG38: 2.011 kcal/mol establishes pivotal strong bonds integral to the interaction between AAS and Zeatin. Rigorous cytotoxicity assessments reveal Zeatin’s safety profile, highlighting its inhibitory effect on LN18 cell viability that sharply decreases to 32.47% at 200 µg/ml, underscoring its modulatory impact on cellular metabolism. These findings enhance our understanding of the convergent mechanisms linking SARS-CoV and AD, providing valuable insights for potential therapeutic interventions. Further research is warranted to elucidate the specific pathways and molecular mechanisms through which zeatin exerts its protective effects.
引用
收藏
相关论文
共 50 条
  • [31] Utility of the aged BALB/c mouse model to demonstrate prevention and control strategies for Severe Acute Respiratory Syndrome coronavirus (SARS-CoV)
    Vogel, Leatrice N.
    Roberts, Anjeanette
    Paddock, Christopher D.
    Genrich, Gillian L.
    Lamirande, Elaine W.
    Kapadia, Sagar U.
    Rose, John K.
    Zaki, Sherif R.
    Subbarao, Kanta
    VACCINE, 2007, 25 (12) : 2173 - 2179
  • [32] The YXXΦ motif within the severe acute respiratory syndrome coronavirus (SARS-CoV) 3a protein is crucial for its intracellular transport
    Rinki Minakshi
    Kartika Padhan
    Virology Journal, 11
  • [33] Long-lived effector/central memory T-cell responses to severe acute respiratory syndrome coronavirus (SARS-CoV) S antigen in recovered SARS patients
    Yang, Li-Tao
    Peng, Hui
    Zhu, Zhao-Ling
    Li, Gang
    Huang, Zi-Tong
    Zhao, Zhi-Xin
    Koup, Richard A.
    Bailer, Robert T.
    Wu, Chang-You
    CLINICAL IMMUNOLOGY, 2006, 120 (02) : 171 - 178
  • [34] Cellular Immune Responses to Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) Infection in Senescent BALB/c Mice: CD4+ T Cells Are Important in Control of SARS-CoV Infection
    Chen, Jun
    Lau, Yuk Fai
    Lamirande, Elaine W.
    Paddock, Christopher D.
    Bartlett, Jeanine H.
    Zaki, Sherif R.
    Subbarao, Kanta
    JOURNAL OF VIROLOGY, 2010, 84 (03) : 1289 - 1301
  • [35] A single immunization with a rhabdovirus-based vector expressing severe acute respiratory syndrome coronavirus (SARS-CoV) S protein results in the production of high levels of SARS-CoV-neutralizing antibodies
    Faber, M
    Lamirande, EW
    Roberts, A
    Rice, AB
    Koprowski, H
    Dietzschold, B
    Schnell, MJ
    JOURNAL OF GENERAL VIROLOGY, 2005, 86 : 1435 - 1440
  • [36] Detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in vaginal swabs of women with acute SARS-CoV-2 infection: a prospective study
    Schwartz, A.
    Yogev, Y.
    Zilberman, A.
    Alpern, S.
    Many, A.
    Yousovich, R.
    Gamzu, R.
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2021, 128 (01) : 97 - 100
  • [37] Quantitative temporal-spatial distribution of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) in post-mortem tissues
    Tang, Julian W.
    To, Ka-Fai
    Lo, Anthony W. I.
    Sung, Joseph J. Y.
    Ng, H. K.
    Chan, Paul K. S.
    JOURNAL OF MEDICAL VIROLOGY, 2007, 79 (09) : 1245 - 1253
  • [38] Polymorphisms in the C-type lectin genes cluster in chromosome 19 and predisposition to severe acute respiratory syndrome coronavirus (SARS-CoV) infection
    Li, H.
    Tang, N. L-S
    Chan, P. K-S
    Wang, C-Y
    Hui, D. S-C
    Luk, C.
    Kwok, R.
    Huang, W.
    Sung, J. J-Y
    Kong, Q-P
    Zhang, Y-P
    JOURNAL OF MEDICAL GENETICS, 2008, 45 (11) : 752 - 758
  • [39] Interferon-beta and interferon-gamma synergistically inhibit the replication of severe acute respiratory syndrome-associated coronavirus (SARS-CoV)
    Sainz, B
    Mossel, EC
    Peters, CJ
    Garry, RF
    VIROLOGY, 2004, 329 (01) : 11 - 17
  • [40] An Overview of Severe Acute Respiratory Syndrome-Coronavirus (SARS-CoV) 3CL Protease Inhibitors: Peptidomimetics and Small Molecule Chemotherapy
    Pillaiyar, Thanigaimalai
    Manickam, Manoj
    Namasivayam, Vigneshwaran
    Hayashi, Yoshio
    Jung, Sang-Hun
    JOURNAL OF MEDICINAL CHEMISTRY, 2016, 59 (14) : 6595 - 6628